期刊
CELL REPORTS
卷 32, 期 9, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2020.108096
关键词
-
类别
资金
- Science Foundation Ireland (SFI)
- Irish Government's Programme for Research in Third-Level Institutions (PRTLI) cycle 5
- European Regional Development Fund
- Breast Cancer Now grant [2015MayPR506]
- SFI grant [16/IA/4476]
- Fondazione Umberto Veronesi
- NUI Galway
DNA replication initiates from multiple origins, and selective CDC7 kinase inhibitors (CDC7is) restrain cell proliferation by limiting origin firing. We have performed a CRISPR-Cas9 genome-wide screen to identify genes that, when lost, promote the proliferation of cells treated with sub-efficacious doses of a CDC7i. We have found that the loss of function of ETAA1, an ATR activator, and RIF1 reduce the sensitivity to CDC7is by allowing DNA synthesis to occur more efficiently, notably during late S phase. We show that partial CDC7 inhibition induces ATR mainly through ETAA1, and that if ATR is subsequently inhibited, origin firing is unleashed in a CDK- and CDC7-dependent manner- Cells are then driven into a premature and highly defective mitosis, a phenotype that can be recapitulated by ETAA1 and TOPBP1 co-depletion. This work defines how ATR mediates the effects of CDC7 inhibition, establishing the framework to understand how the origin firing checkpoint functions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据